Anti-TauC3 Antibodies and Uses Thereof
Copyright © Targeted News Service 2024
2024-12-10
ALEXANDRIA, Virginia, Dec. 10 -- TAUC3 BIOLOGICS LIMITED, London, United Kingdom has been assigned a patent (No. US 12162930 B2, initially filed Sept. 17, 2021) developed by three inventors Daniel Chain, New York, New York; Preeti Bakrania, Stevenage, United Kingdom; and Seema Patel, Stevenage, United Kingdom, for "Anti-TauC3 antibodies and uses thereof." . . .